Ocugen Announces Positive Top-Line Data for Covid19 Vaccine Candidate Covaxin
Malvern, Pa.: A biopharmaceutical company focused on discovering, developing, and commercialising novel gene and cell therapies and vaccines, today announced positive results from the Phase 2/3,…